Profilin 1 overexpression in renal cell carcinoma

International Journal of Urology

Volumn 18, Issue 1, 2011, Pages 63-71

  Minamida, Satoru ^a   Iwamura, Masatsugu ^a   Kodera, Yoshio ^b   Kawashima, Yusuke ^b   Ikeda, Masaomi ^a   Okusa, Hiroshi ^a   Fujita, Tetsuo ^a   Maeda, Tadakazu ^b   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Profilin 1; Proteomics; Renal cancer

Indexed keywords

ALPHA ACTIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN A4; BIOLOGICAL MARKER; CATHEPSIN D; CLUSTERIN; CONNECTIN; ELONGATION FACTOR 1ALPHA; EZRIN; FIBRONECTIN; FILAMIN A; GALECTIN 3; GALECTIN 3 BINDING PROTEIN; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP PROTEIN; KEXIN; MESSENGER RNA; PEROXIREDOXIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROFILIN; PROFILIN I; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE SUBTILISIN; PROTEIN PRECURSOR; PROTEOME; PYRUVATE KINASE; SUBTILISIN; THROMBOSPONDIN 1; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROFILINS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650670385     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02670.x     Document Type: Article

References (28)

1. Amato RJ. Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens. Ann. Oncol. 2005; 16: 7-15.
2. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J. Urol. 1999; 162: 1930-3.
3. Seliger B, Dressler SP, Lichtenfels R, Kellner R. Candidate biomarkers in renal cell carcinoma. Proteomics 2007; 7: 4601-12.
4. Gouttefangeas C, Stenzl A, Stevanovic S, Rammensee HG. Immunotherapy of renal cell carcinoma. Cancer Immunol. Immunother. 2007; 56: 117-28.
5. Vakkalanka BK, Rini BI. Targeted therapy in renal cell carcinoma. Curr. Opin. Urol. 2008; 18: 481-7.
6. Garcia JA, Rini BI. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J. Clin. 2007; 57: 112-25.
7. Gnarra JR, Lerman MI, Zbar B, Linehan WM. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin. Oncol. 1995; 22: 3-8.
8. Mostofi FK, Davis CJ, Sobin LH. Histological Typing of Kidney Tumours (WHO. World Health Organization. International Histological Classification of Tumours). Springer-Verlag, New York, 1998.
9. Yates JR III, Eng JK, McCormack AL, Schieltz D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 1995; 67: 1426-36.
10. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edn. Springer-Verlag, New York, 2002; 323-8.
11. Carlsson L, Nystrom LE, Sundkvist I, Markey F, Lindberg U. Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells. J. Mol. Biol. 1977; 115: 465-83.
12. Honore B, Madsen P, Andersen AH, Leffers H. Cloning and expression of a novel human profilin variant, profilin II. FEBS Lett. 1993; 330: 151-5.
13. Hu E, Chen Z, Fredrickson T, Zhu Y. Molecular cloning and characterization of profilin-3: a novel cytoskeleton-associated gene expressed in rat kidney and testes. Exp. Nephrol. 2001; 9: 265-74.
14. Obermann H, Raabe I, Balvers M, Brunswig B, Schulze W, Kirchhoff C. Novel testis-expressed profilin IV associated with acrosome biogenesis and spermatid elongation. Mol. Hum. Reprod. 2005; 11: 53-64.
15. Chang S, De Camilli P. Glutamate regulates actin-based motility in axonal filopodia. Nat. Neurosci. 2001; 4: 787-93.
16. Fischer M, Kaech S, Wagner U, Brinkhaus H, Matus A. Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat. Neurosci. 2000; 3: 887-94.
17. Higgs HN, Pollard TD. Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 2001; 70: 649-76.
18. Suetsugu S, Miki H, Takenawa T. Distinct roles of profilin in cell morphological changes: microspikes, membrane ruffles, stress fibers, and cytokinesis. FEBS Lett. 1999; 457: 470-4.
19. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003; 112: 453-65.
20. Janke J, Schlüter K, Jandrig B et al. Suppression of tumorigenicity in breast cancer cells by the microfilament protein Profilin 1. J. Exp. Med. 2000; 191: 1675-86.
21. Grønborg M, Kristiansen TZ, Iwahori A et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 2006; 5: 157-71.
22. Wu N, Zhang W, Yang Y et al. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 2006; 6: 6095-106.
23. Oien KA, Vass JK, Downie I, Fullarton G, Keith WN. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 2003; 22: 4287-300.
24. Zou L, Jaramillo M, Whaley D et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br. J. Cancer 2007; 97: 1361-71.
25. Dahl U, Sjödin A, Larue L et al. Genetic dissection of cadherin function during nephrogenesis. Mol. Cell. Biol. 2002; 22: 1474-87.
26. Goto S, Yaoita E, Matsunami H et al. Involvement of R-cadherin in the early stage of glomerulogenesis. J. Am. Soc. Nephrol. 1998; 9: 1234-41.
27. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006; 66: 8319-26.
28. Klymkowsky MW, Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 2009; 174: 1588-93.